AU2068395A - Use of antagonists of egf or tgf-alpha for the treatment and prophylaxis of acne - Google Patents

Use of antagonists of egf or tgf-alpha for the treatment and prophylaxis of acne

Info

Publication number
AU2068395A
AU2068395A AU20683/95A AU2068395A AU2068395A AU 2068395 A AU2068395 A AU 2068395A AU 20683/95 A AU20683/95 A AU 20683/95A AU 2068395 A AU2068395 A AU 2068395A AU 2068395 A AU2068395 A AU 2068395A
Authority
AU
Australia
Prior art keywords
acne
egf
tgf
prophylaxis
antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU20683/95A
Inventor
Alan Evenson
Walter Thomas Gibson
Martin Richard Green
Robert Guy
Terence George Evelyn Kealey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unilever PLC
Original Assignee
Unilever PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever PLC filed Critical Unilever PLC
Publication of AU2068395A publication Critical patent/AU2068395A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A61K8/315—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU20683/95A 1994-03-15 1995-03-08 Use of antagonists of egf or tgf-alpha for the treatment and prophylaxis of acne Abandoned AU2068395A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9405046A GB9405046D0 (en) 1994-03-15 1994-03-15 Skin treatment composition
GB9405046 1994-03-15
PCT/EP1995/000877 WO1995024896A2 (en) 1994-03-15 1995-03-08 Use of antagonists of egf or tgf-alpha for the treatment and prophylaxis of acne

Publications (1)

Publication Number Publication Date
AU2068395A true AU2068395A (en) 1995-10-03

Family

ID=10751891

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20683/95A Abandoned AU2068395A (en) 1994-03-15 1995-03-08 Use of antagonists of egf or tgf-alpha for the treatment and prophylaxis of acne

Country Status (7)

Country Link
EP (1) EP0750498A1 (en)
JP (1) JPH09510228A (en)
AU (1) AU2068395A (en)
CA (1) CA2185675A1 (en)
GB (1) GB9405046D0 (en)
WO (1) WO1995024896A2 (en)
ZA (1) ZA952120B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU737018B2 (en) * 1997-07-25 2001-08-09 Tsumura & Co. Pyridylacrylamide derivatives and nephritis remedies and TGF-beta inhibitors containing the same
AU2003216318B2 (en) 2002-02-19 2006-02-23 The Procter & Gamble Company Lipase inhibiting composition
CN102178930A (en) * 2011-05-17 2011-09-14 华南理工大学 Anti-acne composition containing epidermal growth factors and tea tree oil and preparation method thereof
CN113813369B (en) * 2021-11-09 2023-09-22 浙江省农业科学院 EGF/MMT complex for preventing/treating intestinal injury of piglets

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6236305A (en) * 1985-08-08 1987-02-17 Kao Corp Cosmetic
JPH01501791A (en) * 1986-11-19 1989-06-22 ケメックス　ファーマシューティカルズ，インコーポレイティド Pharmacologically active compounds and mixtures thereof, organic compositions and metal salts
WO1991016892A1 (en) * 1990-04-27 1991-11-14 Rorer International (Holdings), Inc. Styryl compounds which inhibit egf receptor protein tyrosine kinase
DE4033568A1 (en) * 1990-10-22 1992-04-23 Henkel Kgaa BICYCLIC COMPOUNDS WITH ANTISEBORRHOIC EFFECT
JP3330961B2 (en) * 1991-02-22 2002-10-07 株式会社創研 Skin improver
GB9106678D0 (en) * 1991-03-28 1991-05-15 Ferguson Mark W J Wound healing
JPH05105620A (en) * 1991-10-15 1993-04-27 Kao Corp Beautifying cosmetic comprising p-hydroxycinnamic acid derivative as active ingredient
JP2997358B2 (en) * 1992-01-30 2000-01-11 ポーラ化成工業株式会社 External preparation for skin
DE69327620T2 (en) * 1992-08-18 2000-08-03 Centro De Immunologia Molecular, Ciudad De La Habana Monoclonal antibodies to the epidermal growth factor receptor, cells and methods for their preparation and compositions containing them

Also Published As

Publication number Publication date
WO1995024896A3 (en) 1995-11-09
EP0750498A1 (en) 1997-01-02
JPH09510228A (en) 1997-10-14
CA2185675A1 (en) 1995-09-21
ZA952120B (en) 1996-09-16
WO1995024896A2 (en) 1995-09-21
GB9405046D0 (en) 1994-04-27

Similar Documents

Publication Publication Date Title
AUPM672594A0 (en) A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders
AU5687896A (en) Use of alpha 1L-agonists in the treatment of incontinence
AU6974996A (en) Compositions for the treatment of dermatological disorders and methods for their use
AU3201095A (en) Substituted thiazoles for the treatment of inflammation
AU2228297A (en) Use of isoniazid for the treatment of hyperlipoproteinemia
AU4061597A (en) Treatment of the common cold or allergic rhinitis
IL136110A0 (en) Methods and compositions for the treatment of psoriasis
AU6615196A (en) Use of mp52 or mp121 for treating and preventing diseases of the nervous system
HUP9802861A3 (en) Use of calendula glycosides for the treatment of psoriasis
AU2160495A (en) Device for continuous treatment of textile material or the like
AU2424895A (en) Substituted spirodienes for the treatment of inflammation
AU4774597A (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
AU3099997A (en) The use of tcet in the prophylaxis and treatment of allergies
AU2387097A (en) Substituted benzylamines and their use for the treatment of depression
AU1556497A (en) Agents for the treatment and prevention of aids
AU2821295A (en) Compositions and methods for the treatment of tumors
AU7310896A (en) Use of nitroflavonoids for the treatment of anxiety
AU2807492A (en) Use of misoprostol for the treatment of allergy
AU3187595A (en) Compounds for the treatment of restenosis
HK1022267A1 (en) Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis
AU2068395A (en) Use of antagonists of egf or tgf-alpha for the treatment and prophylaxis of acne
EP0852503A4 (en) Composition for the treatment of diarrhea, its use and its preparation
AU4585993A (en) Use of angiotensin ii antagonists for the treatment of hyperlipidaeme
AU5371694A (en) Use of the tarchonanthus camphoratus
DE59711240D1 (en) USE OF FLUPIRTIN FOR THE THERAPY AND PROPHYLAXIS OF MYOKARDINE FARCT, SHOCKNIERE AND SHOCKLUNG